基底细胞样乳腺癌的诊治研究进展  

The research progress of basal-like breast carcinoma

作　　者：张佳玉 翟志伟 李文倩 郭仲甫 赵博志 游思融 张东伟[1] Zhang Jiayu;Zhai Zhiwei;Li Wenqian;Guo Zhongfu;Zhao Bozhi;You Sirong;Zhang Dongwei(Second Hospital Affiliated to Harbin Medical University,Heilongjiang Harbin 150086,China)

机构地区：[1]哈尔滨医科大学附属第二医院,黑龙江哈尔滨150086

出　　处：《现代肿瘤医学》2018年第23期3882-3884,共3页Journal of Modern Oncology

基　　金：黑龙江省科技计划项目(编号:YS17C22)

摘　　要：基底细胞样乳腺癌是一种异质性大、恶性程度高、预后差的乳腺恶性肿瘤,其主要特征是复发率高、患者生存期短、有特殊的转移途径。它易转移到脑及内脏器官。有效的全身系统治疗只有化疗。寻找基底细胞样乳腺癌新的标志物,将成为今后基底细胞样乳腺癌治疗的新方向。Basal-like breast carcinoma is a heterogeneous disease of high malignancy and poor prognosis,which is subordinate to breast carcinoma with high recurrence rate and distinctive route of metastasis.Comparing with osseous metastasis,basal-like breast carcinoma has more feasibility of metastasis to viscera.Chemotherapy is the only effectively therapy of basal-like breast carcinoma.Looking for the marker of basal-like breast carcinoma is supposed to be the tendency of the treatment of the disease.

关 键 词：基底细胞样乳腺癌 三阴性乳腺癌 靶向治疗 

分 类 号：R737.9[医药卫生—肿瘤]